These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2192633)

  • 21. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Ki-ras messenger RNA in normal and chemically transformed hamster oral keratinocytes.
    Wong DT; Gertz R; Chow P; Chang AL; McBride J; Chiang T; Matossian K; Gallagher G; Shklar G
    Cancer Res; 1989 Aug; 49(16):4562-7. PubMed ID: 2501028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene.
    Ciardiello F; Kim N; Hynes N; Jaggi R; Redmond S; Liscia DS; Sanfilippo B; Merlo G; Callahan R; Kidwell WR
    Mol Endocrinol; 1988 Dec; 2(12):1202-16. PubMed ID: 3063955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis.
    Bera TK; Guzman RC; Miyamoto S; Panda DK; Sasaki M; Hanyu K; Enami J; Nandi S
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9789-93. PubMed ID: 7937892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
    Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
    Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
    Kwong YY; Husain Z; Biswas DK
    Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in in vivo chemical carcinogenesis.
    Husain Z; Fei YB; Roy S; Solt DB; Polverini PJ; Biswas DK
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1264-8. PubMed ID: 2493153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.
    Balmain A; Brown K; Bremner R
    Immunol Ser; 1990; 51():75-88. PubMed ID: 2128916
    [No Abstract]   [Full Text] [Related]  

  • 33. Development pattern of human breast and susceptibility to carcinogenesis.
    Russo J; Russo IH
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():85-100. PubMed ID: 7905315
    [No Abstract]   [Full Text] [Related]  

  • 34. Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice.
    Maruyama C; Tomisawa M; Wakana S; Yamazaki H; Kijima H; Suemizu H; Ohnishi Y; Urano K; Hioki K; Usui T; Nakamura M; Tsuchida T; Mitsumori K; Nomura T; Tamaoki N; Ueyama Y
    Oncol Rep; 2001; 8(2):233-7. PubMed ID: 11182032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model.
    Tsuda H; Fukamachi K; Ohshima Y; Ueda S; Matsuoka Y; Hamaguchi T; Ohnishi T; Takasuka N; Naito A
    Cancer Sci; 2005 Jun; 96(6):309-16. PubMed ID: 15958052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An affinity labeling of ras p21 protein and its use in the identification of ras p21 in cellular and tissue extracts.
    Basu A; Modak MJ
    J Biol Chem; 1987 Feb; 262(5):2369-73. PubMed ID: 3546289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of chromosomal aberrations by comparative genomic hybridization during transformation of human breast epithelial cells in vitro.
    Balogh GA; Russo IH; Balsara BR; Russo J
    Int J Oncol; 2006 Oct; 29(4):877-81. PubMed ID: 16964383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.
    Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H
    Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
    D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA
    Nat Med; 2001 Feb; 7(2):235-9. PubMed ID: 11175856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.